-
Sales of generic oncology drugs surge
europeanpharmaceuticalreview
February 21, 2019
A report has forecasted that the generic oncology drugs market could register an impressive 6 percent CAGR up to the year 2028…
-
USPSTF Says Screen Women With Higher Risk for BRCA Mutations
drugs
February 20, 2019
The U.S. Preventive Services Task Force (USPSTF) recommends screening for women at increased risk for carrying a BRCA1/2mutation as well as genetic counseling and testing as indicated for those screening positive.
-
Two new cancer Priority Reviews for Roche
pharmaphorum
February 20, 2019
Roche has announced that the FDA has granted Priority Review to two of its drugs – personalised lung cancer medicine entrectinib and lymphoma treatment polatuzumab vedotin.
-
Researchers develop reversible antiplatelet therapy to fight clotting, cancer metastasis
worldpharmanews
February 18, 2019
A new reversible, drug-free antiplatelet therapy could reduce the risk of blood clots and potentially prevent cancer metastasis, according to a study published today in Science Translational Medicine.
-
Cancer Death Risk Up for Kidney Transplant, Dialysis Patients
drugs
February 15, 2019
Dialysis and kidney transplant patients have more than a 2.5-fold increased risk for cancer death, according to a study published online Feb. 14 in the Journal of the American Society of Nephrology....
-
New insight into cell receptors opens the way for tailored cancer drugs
worldpharmanews
February 12, 2019
New research on how cancer mutations influence a certain type of receptor on the cell membrane opens the way for the development of tailored drugs for certain cancers, such as rectal cancer and lung cancer.
-
Study suggests aspirin may help some patients survive head and neck cancer
worldpharmanews
January 29, 2019
Regular use of aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) may help some patients with head and neck cancer survive the disease...
-
Many New Cancer Patients Unaware of Their Hepatitis Status
drugs
January 23, 2019
A substantial proportion of patients with newly diagnosed cancer and concurrent hepatitis B virus (HBV) or hepatitis C virus (HCV) infection are unaware of their viral infection at the time of cancer diagnosis...
-
US cancer patients trial Proteus’ digital chemotherapy pill
pharmaphorum
January 23, 2019
Cancer patients in the US are trialling digital oncology drugs for the first time, collecting data on patients in a bid to improve outcomes and help adherence.
-
Proteus Digital Health introduces digital medicines for cancer
pharmaceutical-technology
January 21, 2019
In collaboration with Fairview Health Services and University of Minnesota Health in the US, Proteus Digital Health has launched digital medicines to boost outcomes for cancer patients.